Novel Immunotherapy Mechanism Suppresses Breast Cancer Development

 

 

METHOD OF RESEARCH

Experimental study

SUBJECT OF RESEARCH

Animals

ARTICLE TITLE

CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation

ARTICLE PUBLICATION DATE

3-Jun-2022

COI STATEMENT

Disclosures: M. Boieri is an employee of Zelluna Immunotherapy. S. Iyer is an employee of and has equity in Verve Therapeutics. M.N. Rivera reported grants from Advanced Cell Diagnostics and non-financial support from Merck/Serono outside the submitted work. No other disclosures were reported.

withyou android app